KSK120
KSK120 is a potent inhibitor of drug-resistant infections with specific activity against Chlamydia trachomatis (C. trachomatis) . KSK120 inhibits the developmental cycle of C. trachomatis, thereby reducing the infectivity of progeny bacteria. KSK120 targets the glucose-6-phosphate (G-6P) metabolic pathway of C. trachomatis, showing its potential application in antimicrobial inhibition. The mechanism of KSK120 may involve inhibition of the transcriptional machinery, which provides new ideas for the development of specific drugs against C. trachomatis infection[1].
Product Specifications
CAS Number
1638100-63-6
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/ksk120.html
Smiles
O=C(C=C1CC2=CC=CC3=C2C=CC=C3)N4C(C(NC5=CC=CC=C5)=O)=CSC4=C1C6CC6
Molecular Formula
C28H22N2O2S
Molecular Weight
450.55
References & Citations
[1]A 2-pyridone amide inhibitor of transcriptional activity in Chlamydia trachomatis
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Caldesmon, HMW (h-Caldesmon) (CALD1/820 + h-CALD), CF405S conjugate, 0.1mg/mL
![DEF6 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1E3]](https://cdn.genprice.uk/products/937/6868c367994c49e6dc3f6312/imageurl/ta505321bm.webp)